Arbovirus Infections - 106 Studies Found
Completed |
: Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects :
: |
Completed |
: Efficacy and Safety of Dengue Vaccine in Healthy Children :
: |
Completed |
: Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years :
: |
Completed |
: Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults :
: |
Completed |
: Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects :
: |
Completed |
: A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children :
|
Recruiting |
: Postmarketing Surveillance Study for IMOJEV® in Republic of Korea : Japanese Encephalitis : 2016-10-12 : Biological: IMOJEV®: Live attenuated Japanese encephalitis chimeric virus vaccine 0.5 mL, Subcutane |
Completed |
: Safety and Immunogenicity of JECEVAX in Young Children : Japanese Encephalitis : 2016-06-23 :
|
Completed |
: Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine : Japanese Encephalitis : 2015-10-12 : Biological: a live attenuated chimeric JE vaccine The stud |
Completed |
: Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj : Japanese Encephalitis : 2015-08-21 : Biological: Japanese encephalitis vaccine Dosage and administration: After reconstitution with 0.7 mL of |